Par Drugs and Chemicals Limited

NSEI:PAR Stok Raporu

Piyasa değeri: ₹3.5b

Par Drugs and Chemicals Yönetim

Yönetim kriter kontrolleri 3/4

Par Drugs and Chemicals CEO'su Jignesh Savani, Nov2018 tarihinde atandı, in görev süresi 25.75 yıldır. in toplam yıllık tazminatı ₹ 5.19M olup, şirket hissesi ve opsiyonları dahil olmak üzere 99.3% maaş ve 0.7% ikramiyelerden oluşmaktadır. şirketin hisselerinin 42.36% ine doğrudan sahiptir ve bu hisseler ₹ 1.47B değerindedir. Yönetim ekibinin ve yönetim kurulunun ortalama görev süresi sırasıyla 6 yıl ve 6.3 yıldır.

Anahtar bilgiler

Jignesh Savani

İcra Kurulu Başkanı

₹5.2m

Toplam tazminat

CEO maaş yüzdesi99.3%
CEO görev süresi6yrs
CEO sahipliği42.4%
Yönetim ortalama görev süresi6yrs
Yönetim Kurulu ortalama görev süresi6.3yrs

Son yönetim güncellemeleri

Recent updates

There's No Escaping Par Drugs and Chemicals Limited's (NSE:PAR) Muted Earnings Despite A 26% Share Price Rise

Oct 29
There's No Escaping Par Drugs and Chemicals Limited's (NSE:PAR) Muted Earnings Despite A 26% Share Price Rise

Improved Earnings Required Before Par Drugs and Chemicals Limited (NSE:PAR) Stock's 29% Jump Looks Justified

Apr 16
Improved Earnings Required Before Par Drugs and Chemicals Limited (NSE:PAR) Stock's 29% Jump Looks Justified

Here's Why We Think Par Drugs and Chemicals (NSE:PAR) Might Deserve Your Attention Today

Apr 05
Here's Why We Think Par Drugs and Chemicals (NSE:PAR) Might Deserve Your Attention Today

Do Par Drugs and Chemicals' (NSE:PAR) Earnings Warrant Your Attention?

Nov 03
Do Par Drugs and Chemicals' (NSE:PAR) Earnings Warrant Your Attention?

If EPS Growth Is Important To You, Par Drugs and Chemicals (NSE:PAR) Presents An Opportunity

May 19
If EPS Growth Is Important To You, Par Drugs and Chemicals (NSE:PAR) Presents An Opportunity

Does Par Drugs and Chemicals (NSE:PAR) Deserve A Spot On Your Watchlist?

Mar 17
Does Par Drugs and Chemicals (NSE:PAR) Deserve A Spot On Your Watchlist?

Do Par Drugs and Chemicals's (NSE:PAR) Earnings Warrant Your Attention?

Oct 22
Do Par Drugs and Chemicals's (NSE:PAR) Earnings Warrant Your Attention?

Investors Shouldn't Be Too Comfortable With Par Drugs and Chemicals' (NSE:PAR) Robust Earnings

Aug 11
Investors Shouldn't Be Too Comfortable With Par Drugs and Chemicals' (NSE:PAR) Robust Earnings

Here's Why We Think Par Drugs and Chemicals (NSE:PAR) Is Well Worth Watching

Jul 14
Here's Why We Think Par Drugs and Chemicals (NSE:PAR) Is Well Worth Watching

Is Par Drugs and Chemicals Limited (NSE:PAR) An Attractive Dividend Stock?

Mar 31
Is Par Drugs and Chemicals Limited (NSE:PAR) An Attractive Dividend Stock?

Are Strong Financial Prospects The Force That Is Driving The Momentum In Par Drugs and Chemicals Limited's NSE:PAR) Stock?

Mar 05
Are Strong Financial Prospects The Force That Is Driving The Momentum In Par Drugs and Chemicals Limited's NSE:PAR) Stock?

Chairman of the Board & MD Falgun Savani Just Bought A Handful Of Shares In Par Drugs and Chemicals Limited (NSE:PAR)

Feb 06
Chairman of the Board & MD Falgun Savani Just Bought A Handful Of Shares In Par Drugs and Chemicals Limited (NSE:PAR)

Here's Why I Think Par Drugs and Chemicals (NSE:PAR) Might Deserve Your Attention Today

Jan 10
Here's Why I Think Par Drugs and Chemicals (NSE:PAR) Might Deserve Your Attention Today

How Does Par Drugs and Chemicals Limited (NSE:PAR) Fare As A Dividend Stock?

Dec 13
How Does Par Drugs and Chemicals Limited (NSE:PAR) Fare As A Dividend Stock?

CEO Tazminat Analizi

Jignesh Savani'un ücretlendirmesi Par Drugs and Chemicals'un kazancına kıyasla nasıl değişti?
TarihToplam TazminatMaaşŞirket Kazançları
Sep 30 2024n/an/a

₹183m

Jun 30 2024n/an/a

₹146m

Mar 31 2024₹5m₹5m

₹145m

Dec 31 2023n/an/a

₹142m

Sep 30 2023n/an/a

₹127m

Jun 30 2023n/an/a

₹115m

Mar 31 2023₹5mn/a

₹113m

Dec 31 2022n/an/a

₹103m

Sep 30 2022n/an/a

₹106m

Jun 30 2022n/an/a

₹91m

Mar 31 2022₹5m₹5m

₹92m

Dec 31 2021n/an/a

₹112m

Sep 30 2021n/an/a

₹112m

Jun 30 2021n/an/a

₹115m

Mar 31 2021₹4m₹4m

₹116m

Dec 31 2020n/an/a

₹88m

Sep 30 2020n/an/a

₹83m

Jun 30 2020n/an/a

₹65m

Mar 31 2020₹4mn/a

₹48m

Tazminat ve Piyasa: Jignesh 'nin toplam tazminatı ($USD 61.36K ), Indian pazarındaki benzer büyüklükteki şirketler için ortalamanın üzerindedir ($USD 42.61K ).

Tazminat ve Kazançlar: Jignesh 'in tazminatı, şirketin son bir yıldaki performansıyla tutarlıydı.

CEO

Jignesh Savani (47 yo)

6yrs

Görev süresi

₹5,185,000

Tazminat

Mr. Jignesh Vallabhbhai Savani is Promoter of at Par Drugs and Chemicals Limited and has been its Chief Executive Officer since November 26, 2018 and serves as its Executive Director since February 26, 199...

Liderlik Ekibi

İsimPozisyonGörev süresiTazminatSahiplik
Falgun Savani
Chairman of the Board & MD25.8yrs₹5.21m21.5%
₹ 744.6m
Jignesh Savani
CEO & Executive Director6yrs₹5.19m42.36%
₹ 1.5b
Chintan Chauhan
Chief Financial Officer6yrs₹589.00kVeri yok
Sanket Trivedi
Company Secretary & Compliance Officer6.2yrs₹663.00kVeri yok
Ghanshayambhai Savani
Whole Time Director6yrs₹5.18m6.52%
₹ 225.8m

6.0yrs

Ortalama Görev Süresi

47yo

Ortalama Yaş

Deneyimli Yönetim: PAR 'un yönetim ekibi deneyimli ve deneyimlidir ( 6 yıldır).

Yönetim Kurulu Üyeleri

İsimPozisyonGörev süresiTazminatSahiplik
Falgun Savani
Chairman of the Board & MD25.8yrs₹5.21m21.5%
₹ 744.6m
Jignesh Savani
CEO & Executive Director25.8yrs₹5.19m42.36%
₹ 1.5b
Ghanshayambhai Savani
Whole Time Director12.6yrs₹5.18m6.52%
₹ 225.8m
Pravin Bhayani
Lead Independent Director5.8yrs₹1.29mVeri yok
Kajal Vaghani
Independent Director5.8yrs₹40.00kVeri yok
Krishna Shah
Independent Director5.8yrs₹90.00kVeri yok
Nayna Savani
Non Executive Director6.8yrs₹50.00k3.08%
₹ 106.6m
Bintal Bhaveshkumar Shah
Independent Director4.2yrs₹25.00kVeri yok

6.3yrs

Ortalama Görev Süresi

47.5yo

Ortalama Yaş

Deneyimli Yönetim Kurulu: PAR 'nin yönetim kurulu üyeleri deneyimli olarak kabul edilir (ortalama görev süresi 6.3 yıldır).